Barry J. Hoffer
Affiliations: | National Institute on Drug Abuse |
Area:
PharmacologyWebsite:
http://www.drugabuse.gov/DIR/cell-neuro.htmlGoogle:
"Barry Hoffer"Mean distance: 12.89 (cluster 6) | S | N | B | C | P |
Cross-listing: Chemistry Tree
Parents
Sign in to add mentorLowell Winship Lapham | post-doc | 1967-1968 | Rochester |
Floyd E. Bloom | post-doc | 1968-1970 | NIMH |
Children
Sign in to add traineeJaime M. Ross | grad student | 2006-2012 | Karolinska Institutet - NIDA |
Cristina Backman | post-doc | NIDA | |
Paula C. Bickford | post-doc | CU Boulder | |
Tom Dunwiddie | post-doc | CU Boulder | |
Greg Gerhardt | post-doc | NIDA | |
Ann-Charlotte Granholm | post-doc | CU Boulder | |
Brandon K. Harvey | post-doc | NIDA | |
Ingrid Stromberg | post-doc | CU Boulder | |
David A. Taylor | post-doc | 1974-1977 | CU Boulder |
Collaborators
Sign in to add collaboratorLars Olson | collaborator | Center for Hearing and Communication, Karolinska Institutet, Sweden | |
Richard Jay Smeyne | collaborator | 2012- | Case Western Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Glotfelty EJ, Tovar-Y-Romo LB, Hsueh SC, et al. (2023) The RhoA-ROCK1/ROCK2 Pathway Exacerbates Inflammatory Signaling in Immortalized and Primary Microglia. Cells. 12 |
Kuo TT, Chen YH, Wang V, et al. (2023) PT320, a Sustained-Release GLP-1 Receptor Agonist, Ameliorates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. International Journal of Molecular Sciences. 24 |
Tseng KY, Kuo TT, Wang V, et al. (2022) Tetrabenazine Mitigates Aberrant Release and Clearance of Dopamine in the Nigrostriatal System, and Alleviates L-DOPA-Induced Dyskinesia in a Mouse Model of Parkinson's Disease. Journal of Parkinson's Disease |
Chen YH, Wu KJ, Hsieh W, et al. (2021) Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein. Genes. 12 |
Wang V, Kuo TT, Huang EY, et al. (2021) Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease. Acs Pharmacology & Translational Science. 4: 858-869 |
Yu SJ, Chen S, Yang YY, et al. (2020) PT320, Sustained-Release Exendin-4, Mitigates L-DOPA-Induced Dyskinesia in a Rat 6-Hydroxydopamine Model of Parkinson's Disease. Frontiers in Neuroscience. 14: 785 |
Tweedie D, Karnati HK, Mullins R, et al. (2020) Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury. Elife. 9 |
Lin CT, Lecca D, Yang LY, et al. (2020) 3,6'-Dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation. Elife. 9 |
Chen YH, Yu SJ, Wu KJ, et al. (2020) Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody. Journal of Parkinson's Disease |
Chen YH, Wang V, Huang EY, et al. (2019) Delayed Dopamine Dysfunction and Motor Deficits in Female Parkinson Model Mice. International Journal of Molecular Sciences. 20 |